Major pharmaceutical players Eli Lilly (NYSE:LLY), AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) reported mixed Q3 results, with each company facing distinct market forces, ranging from supply issues to financial constraints. In its latest quarterly report, released on Wednesday (October 30), Eli Lilly missed on sales expectations for Zepbound, its popular weight-loss…
Piche Resources Limited (ASX: PR2) (“Piche” or the “Company”) is pleased to announce drilling results from a further eight…
Fission Uranium (TSX:FCU,OTCQX:FCUUF) has expanded its uranium exploration portfolio in and around Northern Saskatchewan’s Athabasca Basin by staking four…
Wall Street had a mixed week, with indexes rising early in the week but closing lower on Thursday (October…
Astral Resources NL (ASX: AAR) (Astral or the Company) is pleased to report an updated JORC compliant (2012 Edition)…
The company is strategically positioned to capitalize on the growing demand for these valuable resources driven by several key…
Argyle Resources (CSE:ARGL,OTCQB:ARLYF) released an update about its pilot processing facility in St-Lambert-de-Lauzon, Québec, as it prepares for exploration…
Mining giant BHP (ASX:BHP,NYSE:BHP,LSE:BHP) and Toyota Australia are set to complete a trial for the first battery-electric HiLux double-cab…
Asian Battery Metals PLC (ABM or the Company, ASX: AZ9) is pleased to report the results of the remaining…